Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhou Yi-wu

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Fa Yi Xue Za Zhi|August 18, 2004
[A primary study on the gene expression profiling of human brain contusion by cDNA microarray]Zhou Yi-wu, Zhang Yi-gu, Liu Yan
European Journal of Pharmacology|March 24, 2019
Farnesoid X receptor agonist GW4064 indirectly inhibits HCV entry into cells via down-regulating scavenger receptor class B type IZhou-Yi Wu, Hu Li, Jian-Rui Li, et al.
Plos One|March 27, 2015
Host APOBEC3G protein inhibits HCV replication through direct binding at NS3Yan-Ping Zhu, Zong-Gen Peng, Zhou-Yi Wu, et al.
Bioorganic & Medicinal Chemistry Letters|March 22, 2017
Evolution of matrinic ethanol derivatives as anti-HCV agents from matrine skeletonYing-Hong Li, Zhou-Yi Wu, Sheng Tang, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|June 8, 2018
[The influence of intracellular keratin 8 on hepatitis C virus replication]Wen-jing Li, Jian-rui Li, Meng-hao Huang, et al.
International Journal of Molecular Medicine|October 18, 2017
Internal driving factors leading to extrahepatic manifestation of the hepatitis C virus infectionZhou-Yi Wu, Jian-Rui Li, Meng-Hao Huang, et al.
Biomed Research International|September 15, 2017
A Simple but Accurate Method for Evaluating Drug-Resistance in Infectious HCVcc SystemJian-Rui Li, Wen-Jing Li, Jun-Jun Cheng, et al.
Scientific Reports|February 23, 2016
CD36 is a co-receptor for hepatitis C virus E1 protein attachmentJun-Jun Cheng, Jian-Rui Li, Meng-Hao Huang, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Fa Yi Xue Za Zhi|August 18, 2004
[A primary study on the gene expression profiling of human brain contusion by cDNA microarray]Zhou Yi-wu, Zhang Yi-gu, Liu Yan
European Journal of Pharmacology|March 24, 2019
Farnesoid X receptor agonist GW4064 indirectly inhibits HCV entry into cells via down-regulating scavenger receptor class B type IZhou-Yi Wu, Hu Li, Jian-Rui Li, et al.
Plos One|March 27, 2015
Host APOBEC3G protein inhibits HCV replication through direct binding at NS3Yan-Ping Zhu, Zong-Gen Peng, Zhou-Yi Wu, et al.
Bioorganic & Medicinal Chemistry Letters|March 22, 2017
Evolution of matrinic ethanol derivatives as anti-HCV agents from matrine skeletonYing-Hong Li, Zhou-Yi Wu, Sheng Tang, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|June 8, 2018
[The influence of intracellular keratin 8 on hepatitis C virus replication]Wen-jing Li, Jian-rui Li, Meng-hao Huang, et al.
International Journal of Molecular Medicine|October 18, 2017
Internal driving factors leading to extrahepatic manifestation of the hepatitis C virus infectionZhou-Yi Wu, Jian-Rui Li, Meng-Hao Huang, et al.
Biomed Research International|September 15, 2017
A Simple but Accurate Method for Evaluating Drug-Resistance in Infectious HCVcc SystemJian-Rui Li, Wen-Jing Li, Jun-Jun Cheng, et al.
Scientific Reports|February 23, 2016
CD36 is a co-receptor for hepatitis C virus E1 protein attachmentJun-Jun Cheng, Jian-Rui Li, Meng-Hao Huang, et al.
Pageof 1